Launch of the Implementation of Strategy and Roadmap for Trans-fatty Acids (TFAs) Regulation
Keynote Speech by Prof. Adeyeye C M, Director General NAFDAC Launch of the Implementation of Strategy and Roadmap for Trans-fatty Acids (TFAs) Regulation 28th September, 2025. Protocol The Coordinating Minister of Health, Federal Ministry of Health and Social Welfare (FMOHSW), ably represented by Director/Head, Food Safety and Quality Programme, Mr. John Atanda World Health Organization (WHO) […]
List of Withdrawn, Suspended and Cancelled products as approved by NAFDAC
This is to inform the General Public that the following products are approved for withdrawal, suspension and cancellation by NAFDAC. They are therefore no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale and use within Nigeria. Please note that: 1. The Certificate of Registration of a product is said to be withdrawn when […]
Updated Public Alert No. 030A/2025 – Sale of Confirmed Substandard ARTEMETRIN DS Tablets
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the sale of confirmed substandard ARTEMETRIN DS Tablets. The ARTEMETRIN DS (Artemether/Lumefantrine) tablet (80mg/480mg) is registered product labelled as manufactured by A.C. DRUGS Ltd, Plot C5/C6 Old Airport Road, Emene, Enugu State, Nigeria. The product is sub-standard. The product […]
Public Alert No. 030B/2025 – Sale of Confirmed Falsified CIPROFIT 500
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the sale of confirmed Falsified CIPROFIT 500 in Nigeria. The CIPROFIT 500 (Ciprofloxacin Tablet USP 500mg) is labelled manufactured by Impact Pharmaceutical Ltd, No. 33A/33B Standard Industrial Layout Emene-Enugu State, Nigeria. However, it is a falsified product. The product […]
